Opioid-Related Emergency Department Visits Before and During COVID-19: Association with Community-Level Factors.  Page TF, Chen W, Sainfort F, Jacko JA.  HCA Healthc J Med. 2024 Apr 30;5(2):87-95. doi: 10.36518/2689-0216.1608. PMID: 38...

Challenges and Implications for Substance Use and Mental Healthcare Among Under-Resourced Women in the COVID-19 Era.  Mejia MC, Kowalchuk A, Gonzalez SJ, Nair M, Webb L, Scamp N.  Cureus. 2024 Jun 15;16(6):e62452. doi: 10.7759/cureus.6...

Profiling and assessing the risks of image- and performance-enhancing drugs use during the COVID-19 lockdown.  De Luca I, Di Carlo F, Burkauskas J, Dores AR, Carvalho IP, Gómez-Martínez MÁ, Szabo A, Fujiwara H, Barbosa CM, Di Nicola M, Mazza...

Factors associated with SARS-CoV-2 testing, diagnosis and COVID-19 disease among individuals prescribed opioid-agonist treatment: a nationwide retrospective cohort study.  Glancy M, Yeung A, McAuley A, Palmateer N, Bishop J, Taylor B, Lang J...

Police-referred psychiatric emergency presentations during the first and second wave of COVID-19 in Berlin, Germany: a retrospective chart review.  Goldschmidt T, Kippe YD, Gutwinski S, Deutscher K, Schouler-Ocak M, Kroehn-Liedtke F.  ...

Consumption of illicit drugs and benzodiazepines in six Spanish cities during different periods of the COVID-19 pandemic.  Gracia-Lor E, Pérez-Valenciano A, De Oro-Carretero P, Ramírez-García L, Sanz-Landaluze J, Martín-Gutiérrez MJ.  ...